I hope that I'm not bringing up something we have already discussed, but did not see it in any of our former posts. This is from the ADA and the EASD:
"In a move that initially seems surprising, the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) released a joint statement questioning the utility of the term "metabolic syndrome," and discouraging doctors from using it."
"The two diabetes associationsobject to the use of the term "metabolic syndrome." They say that this is not a discrete disease in itself, but merely a clustering of cardiovascular risk factors, and have asked doctors to stop "labeling millions of people with a presumed disease that does not stand on firm ground." Doctors, they say, should not try to treat this presumed disease as a whole, but should simply address each one of the risk factors encompassed by metabolic syndrome individually. They object to the use of metabolic syndrome as a specific target of therapy in clinical trials, such as those testing rimonabant. How can investigators and drug companies, they ask, target a disease that may not even exist?
The joint statement is very perplexing to the tens of thousands of doctors who have been trying to help their patients cope with metabolic syndrome."
Any thoughts about this?